Author: Site Editor Publish Time: 2025-07-02 Origin: Site
At the recently concluded CPHI China 2025, Jiabo Pharma demonstrated its expertise through a high-value portfolio of injectables, fostering meaningful engagement with global partners and industry peers.
Our booth showcased JIABO's core competencies in anesthesia and perioperative injectables, including Propofol Injectable Emulsion(LCT, MCT/LCT), Rocuronium Bromide Injection, Ropivacaine HCl Injection and Parenteral Nutrition etc. The exhibition drove substantial commercial interest, with international visitors initiating in-depth discussions on collaboration opportunities.
We strengthened relationships with existing partners and established connections with prospective distributors and key accounts, paving the way for accelerated global market penetration.
To all who visited our booth—thank you. Your engagement fuels our commitment to advancing perioperative care.
Moving forward, Jiabo Pharma remains dedicated to our mission—Focusing on Perioperative and Specialty Injectables. We look forward to forging strategic partnerships to build a healthier future globally.
